LEADING clinical AI scribe Heidi has announced the launch of Heidi Evidence, a new clinical-grade research tool integrated directly into the Heidi platform.
Based on partnerships with HealthPathways, EMGuidance, MIMS, Vidal, NICE and the BMJ Group, the platform is designed to deliver real-time clinical insights while ensuring guidance reflects regional standards and formularies.
With the concurrent launch of Heidi Comms, an AI partner for healthcare teams to coordinate patient communications across calls, bookings, reminders and follow-ups, the company said Heidi is evolving from an AI scribe "into a comprehensive AI care partner".
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Feb 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Feb 26
